Delivery Order SPE2DB22D3301-SPE2DB24FY4UF
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of Venofer 100 mg/5 ml vials, with a firm fixed price of $4,661.18 and a completion date of February 20, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of...
- This contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of Venofer 100 mg/5 ml vials, a pharmaceutical product used in the treatment of iron deficiency anemia. The $3,119.19 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency that provides medical supplies and equipment to military treatment facilities. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Venofer 100 mg/5 ml vials, a medication used to treat iron deficiency anemia. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $9,137.72 and a performance period through January 23, 2024. The contract was awarded on January 22, 2024 and does not have a set-aside...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,293.72, is for the supply of VENOFER 100 MG/5 ML VIAL 5ML, a medication used in the treatment of iron deficiency anemia. The contract has an ultimate completion date of April 30, 2024. This delivery order is issued under AmerisourceBergen's existing...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 200 mg/10 mL vials of the pharmaceutical product Venofer, with a total ceiling value of $4,279.92 and a completion date of February 10, 2023. The contract is not associated with a set-aside designation. AmerisourceBergen Drug Corp has received numerous prior contract awards from DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,121.06, is for the delivery of Venofer 200 mg/10 ml vials to support military healthcare programs. The contract has a firm fixed price pricing type and a completion date of November 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,738.94 to AmerisourceBergen Drug Corp for the supply of Venofer 100 mg/5 ml vials. This firm fixed-price delivery order, executed on December 22, 2025, with completion scheduled for December 23, 2025, was awarded without set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- This federal contract award is for the delivery of Venofer 100 mg/5 ml vials to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 20, 2023, with a total ceiling value of $4,239.04. The contract is a Firm Fixed Price Delivery Order with a completion date of May 22, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which has a significant Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 20, 2025, for Venofer (iron sucrose) 100 mg/5 ml vials with a ceiling value of $2,454.96 and an ultimate completion date of June 23, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award based on merit. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,005.59 firm fixed-price contract is for the delivery of VENOFER 200 MG/10 ML VIAL 10ML, a pharmaceutical product, with a completion date of April 4, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY4UFDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The $4,439.86 firm fixed-price contract is for the supply of 100 mg/5 ml Venofer vials, a prescription iron supplement medication. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 4/16/24 |